Reducing Vascular Risk in Patients Living with Diabetes

Determine which patients with diabetes require vascular protective therapy

The global unit selector only affects unanswered questions
1.Cardiovascular Disease?
2.Microvascular Disease?
3.Diabetes Type?
4.Diabetes Duration >15 Years?
5.A1c Above Target (>7.0%)?
7.Does the Patient Have at Least One of These Risk Factors?
Created by

1. Cardiovascular Disease?

More Information

• Angina; previous MI; previous PTCI; previous CABG

• Peripheral artery disease: claudication, peripheral bypass

• Cerebrovascular disease: TIA, CVA

Created by
0/7 completed

About this Calculator

This tool was developed based on the 2018 Diabetes Canada Clinical Practice Guidelines for the Prevention and Management of Diabetes. Published every five years, these guidelines represent the best and most current evidence-based clinical practice data for healthcare professionals.

Diabetes significantly accelerates the development and natural history of cardiovascular disease compared to individuals without diabetes. Healthy behaviour interventions and pharmacological approaches aimed at cardiovascular disease risk reduction can significantly reduce morbidity and mortality, and are an important cornerstone of the management of diabetes.


Stone, J. A., Houlden, R. L., Lin, P., Udell, J. A., Verma, S.

Cardiovascular Protection in People With Diabetes.

Canadian Journal of Diabetes 2018, 42 Suppl 1: S162-S169

Contributed By:
  • Benjamin Mammon, MD Candidate
Legal Notices and Disclaimer

© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.